Published August 18, 2021 | Version v1

Treatment of deep vein thrombosis using Factor Xa inhibitor during platinum based chemotherapy regimen

  • 1. Hospital Seri Manjung, Perak, Ministry of Health, Malaysia

Description

Deep Vein Thrombosis (DVT) is a common treatment-related complication following surgery and chemotherapy. We are reporting a case of cancer-associated thrombosis for a colorectal patient receiving platinum-based chemotherapy. The patient was treated with Rivaroxaban (Xarelto), a highly selective direct Factor Xa inhibitor.  This case report highlights the concurrent use of novel oral anticoagulants, which does not interrupt the chemotherapy schedule among patients receiving cytotoxic agents. 

 

Disclaimer: Abstract text might vary slightly from what is displayed in the e-poster.

Notes

This poster was submitted to the 14th National Conference for Clinical Research (NCCR) in August 18-20, 2021. https://nccrconference.com.my/

Files

169.(Wan Mohd Akmal)_(P-169)_(Treatment of deep vein thrombosis using Factor Xa inhibitor concurrent with platinum based chemotherapy regimen a case report).pdf